Quidel Corp (QDEL.OQ)
QDEL.OQ on NASDAQ Stock Exchange Global Select Market
26.95USD
1 Aug 2013
26.95USD
1 Aug 2013
Price Change (% chg)
$0.18 (+0.67%)
$0.18 (+0.67%)
Prev Close
$26.77
$26.77
Open
$27.00
$27.00
Day's High
$27.12
$27.12
Day's Low
$26.68
$26.68
Volume
55,571
55,571
Avg. Vol
53,587
53,587
52-wk High
$29.74
$29.74
52-wk Low
$14.94
$14.94
About
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for... (more)
Overall
| Beta: | 0.66 |
| Market Cap (Mil.): | $902.98 |
| Shares Outstanding (Mil.): | 33.73 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| QDEL.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 50.56 | 66.39 | 37.76 |
| EPS (TTM): | 0.53 | -- | -- |
| ROI: | -- | 4.99 | 18.76 |
| ROE: | -- | 9.80 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Becton, Dickinson and Co. (BDX.N) | $103.11 | -0.61 |
| Alere Inc (ALR.N) | $34.16 | +0.76 |
| Alere Inc (ALR_pb.N) | $277.30 | +0.29 |
| Meridian Bioscience, Inc. (VIVO.OQ) | $24.86 | +0.32 |
| Bristol Myers Squibb Co. (BMY.N) | $43.99 | +0.75 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Eli Lilly & Co. (LLY.N) | $53.50 | +0.39 |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

